Antipsychotic News and Research

RSS

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.

Study proposes improvements in pharmacological study of cognitive function enhancers in schizophrenia

Schizophrenia is a serious, chronic mental disorder involving a series of symptoms. It is one of the leading causes of disability worldwide.

16 Jan 2019

Researchers aim to improve cognition, reverse weight gain in schizophrenia

Aerobic exercise can improve the size and function of the brain, and now investigators want to know if it can also improve cognitive function in patients with schizophrenia who struggle with memory and attention problems.

19 Dec 2018

Assisted living’s breakneck growth leaves patient safety behind

They found Bonnie Walker's body floating in a pond behind her assisted living facility in South Carolina. There were puncture wounds on her ear, her temple, her jaw and her cheeks.

17 Dec 2018

Study highlights need for personalized approach to treat ICU acquired delirium

A population heath study from the Regenstrief Institute and Indiana University Center for Aging Research has determined that halo, did not benefit elective thoracic surgery ICU patients when given prophylactically, with the possible exception of those who have had surgery to remove their esophagus.

14 Dec 2018

Findings reinforce guidelines for cautious use of antipsychotics in younger populations

Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry.

13 Dec 2018

Innovative care model for children with ASD reduces use of behavioral drugs in ED

An innovative care model developed by Nemours Children's Hospital for children with autism spectrum disorders in the emergency department reduces the use of medication administered to kids who are prone to stress and sensory overload in this care setting.

11 Dec 2018

Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression

Researchers at McLean Hospital will lead a five-year study to investigate the use of electroconvulsive therapy to treat severe agitation and aggression in people with Alzheimer's disease.

11 Dec 2018

Podcast: KHN’s ‘What the Health?’ Reading the tea leaves in blue wave’s wake

This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.

29 Nov 2018

$Alternative drug linked with comparable risk of falls, major fractures as atypical antipsychotics in older dementia patients$

Alternative drug linked with comparable risk of falls, major fractures as atypical antipsychotics in older dementia patients

As physicians attempt to decrease antipsychotic use in seniors with dementia, they need to be aware that trazadone, frequently used as an alternative, is associated with a similar risk of falls and major fractures as atypical antipsychotics, according to new research in CMAJ.

26 Nov 2018

Pharmacogenetic tests don't provide much information for prescribing antidepressants or antipsychotics

Pharmacogenetic tests are marketed as an aid to psychiatrists in selecting the antidepressant or antipsychotic medication that will work best in individual patients, based on their genetic makeup.

21 Nov 2018

With hospitalization losing favor, judges order outpatient mental health treatment

When mental illness hijacks Margaret Rodgers' mind, she acts out. Rodgers, 35, lives with depression and bipolar disorder. When left unchecked, the conditions drive the Alabama woman to excessive spending, crying and mania.

13 Nov 2018

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online today in the American Journal of Psychiatry.

5 Nov 2018

Doctors find no association between autism and drugs taken during pregnancy

A new study has found that babies exposed to medications in the womb are at no more risk of developing autism than babies who are not exposed to any drugs.

31 Oct 2018

LSD changes the communication patterns between the brain regions, shows study

LSD changes the communication patterns between regions of the brain, a new study by researchers of the University of Zurich and Yale University shows.

30 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Up to half of people with Alzheimer's disease use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

1 Oct 2018

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis -- a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions -- researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.

27 Sep 2018

Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease

Persons with Alzheimer's disease are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows.

18 Sep 2018

Childhood adversity associated with impaired social cognition in adults with major psychiatric disorders

A new report published in European Psychiatry identified a significant association between childhood adversity and impaired social cognitive functioning among adults diagnosed with major psychiatric disorders.

12 Sep 2018

Dopamine receptor study opens door to targeted treatments for neuropsychiatric disorders

New work from researchers at Columbia University Vagelos College of Physicians and Surgeons sheds light on how dopamine receptors signal within cells, opening the door for more targeted--and more tolerable--therapeutics to treat an array of neuropsychiatric disorders.

4 Sep 2018